First Time Loading...

Tiziana Life Sciences Ltd
NASDAQ:TLSA

Watchlist Manager
Tiziana Life Sciences Ltd Logo
Tiziana Life Sciences Ltd
NASDAQ:TLSA
Watchlist
Price: 0.745 USD 5.66% Market Closed
Updated: May 4, 2024

Tiziana Life Sciences Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tiziana Life Sciences Ltd
Operating Income Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Tiziana Life Sciences Ltd
NASDAQ:TLSA
Operating Income
-$14.6m
CAGR 3-Years
-14%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Operating Income
-$171.3m
CAGR 3-Years
-154%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Operating Income
-$175.5m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Operating Income
-$179.9m
CAGR 3-Years
-47%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Operating Income
-£59.6m
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Operating Income
£53m
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
4%

See Also

What is Tiziana Life Sciences Ltd's Operating Income?
Operating Income
-14.6m USD

Based on the financial report for Dec 31, 2022, Tiziana Life Sciences Ltd's Operating Income amounts to -14.6m USD.

What is Tiziana Life Sciences Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-7%

Over the last year, the Operating Income growth was 47%. The average annual Operating Income growth rates for Tiziana Life Sciences Ltd have been -14% over the past three years , -7% over the past five years .